Share on StockTwits

Arotech (NASDAQ:ARTX) CEO Robert S. Ehrlich sold 8,500 shares of the company’s stock on the open market in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $4.20, for a total value of $35,700.00. Following the transaction, the chief executive officer now directly owns 1,343,545 shares in the company, valued at approximately $5,642,889. The sale was disclosed in a document filed with the SEC, which is available at this link.

Arotech (NASDAQ:ARTX) traded down 0.71% during mid-day trading on Tuesday, hitting $4.17. The stock had a trading volume of 166,231 shares. Arotech has a 1-year low of $1.00 and a 1-year high of $6.61. The stock’s 50-day moving average is $3.96 and its 200-day moving average is $3.56. The company has a market cap of $81.6 million and a price-to-earnings ratio of 28.19.

Arotech (NASDAQ:ARTX) last announced its earnings results on Tuesday, May 13th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.04. The company had revenue of $22.40 million for the quarter, compared to the consensus estimate of $21.30 million. On average, analysts predict that Arotech will post $0.33 earnings per share for the current fiscal year.

A number of research firms have recently commented on ARTX. Analysts at B. Riley upgraded shares of Arotech from a “neutral” rating to a “buy” rating in a research note on Monday, May 12th. They now have a $5.00 price target on the stock. They noted that the move was a valuation call.

Arotech Corporation is a defense and security products and services company, engaged in three business areas: high-level armoring for military and nonmilitary air and ground vehicles; interactive simulation for military, law enforcement and commercial markets, and batteries and charging systems for the military.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.